Skip to main content

Eye Supplements Market 2021, Size, Share, Growth, Trends, Value, Analysis, Market Dynamics, Forecast Report till 2026

Written by Customer Service on . Posted in Mergers And Acquisitions.

Pune, India, Feb. 10, 2021 (GLOBE NEWSWIRE) — According to the report, Eye Supplements market size is projected to reach remarkable value by 2026. The increasing need for maintaining healthy 6/6 eyesight has propelled the demand for eye supplements in the market. Rising awareness about eye diseases is a major factor boosting the global eye supplements market, says Fortune Business Insights in their new study.The World Health Organization reported an estimate of 188.5 million people to suffer from severe vision impairment in terms of distant vision in the year 2018. In 2014, the National Eye Institute stated an estimate of 2.7 million Americans suffered from glaucoma that is expected to reach 4.3 million by the end of 2030. In the same year, the National Eye Institute also estimated that an approximate of 2.1 million of the American population suffered from advanced age-related muscular degeneration (AMD). This is further anticipated to increase and reach 3.7 million Americans by the end of 2030.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/eye-supplements-market-100347
Rising Awareness about Eye Infections and their Preventive Measures to Drive Growth
           
Increasing awareness about eye diseases and preventive eye care measures for avoiding such problems is a major booster for the global eye supplements market. Major causes of eye problems include exposure to harmful agents and pollutants, long working hours in front of computer screens, increase in eye stress. All such problems propel the demand for eye supplements in the market and this is likely to increase during the forecast period.Additionally, the increasing prevalence of eye diseases, such as cataract, AMD, dry eye, low vision, macular degeneration, and others, especially among the geriatric population is a major factor driving the market for eye supplements worldwide.However, the presence of alternative eye treatment procedures may restrict the growth of eye supplements in the market. This, cou0pled with, the problem of product recalls may also hinder the growth of the market during the forecast period.
           
INDUSTRY DEVELOPMENT:In April 2019, Algatechnologies, Ltd. announced the launch of AstaPure-EyeQ, a natural cold water soluble astaxanthin powder to protect the eye from radiations and oxidative stress.In May 2016, OmniActive Health Technologies received European patent for Lutemax 2020, covering the process of preparation and composition of Lutemax 2020.In October 2015, DSM and Kemin Industries, Inc. announced the launch of FloraGLO Lutein and OPTISHARP Zeaxanthin, with the aim to diversify their product portfolio.In May 2015, Douglas Laboratories launched Ultra Preventive Vision, Macu-Support, and Eye Moisture Support in order to support healthy eye functioning.
Click here to get the short-term and long-term impacts of COVID-19 on this Market.Please visit: https://www.fortunebusinessinsights.com/industry-reports/eye-supplements-market-100347
Increasing Number of Eye Care Centres to Help Market Witness Fastest Growth in Asia PacificIt is likely to remain dominant in the coming years as well. Besides this, the global eye supplements market is anticipated to witness growth at a faster rate in Asia Pacific due to the rising awareness about eye problems and improved affordability and accessibility for eye care products. This, coupled with the increasing number of eye care centers and ophthalmologists in the emerging economies such as China and India, is anticipated to bring lucrative growth opportunities for the eye supplements market in Asia Pacific during the forecast duration.
Quick Buy –  Eye Supplements Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/100347
Several companies present in the global market for Eye Supplements are striving to compete with their rivals by either engaging in mergers & acquisitions, or by conducting novel clinical research studies.Nature’s Bounty Co.Amway Corp.Butterflies Healthcare LtdValeant Pharmaceuticals International Inc.Novartis AGBausch & Lomb IncorporatedAkorn IncorporatedAlliance PharmaPfizer IncVitabiotics Ltd
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/queries/eye-supplements-market-100347
Global Eye Supplements Market Segmentation:By Product Type        AntioxidantsFatty AcidsAnti-inflammatory SupplementsNeuro-protective supplementsOthersBy Form         LiquidGelsCapsuleTabletBy Application          Eye HealthMuscular DegenerationDiabetic RetinopathyCataractGlaucomaOthersBy Distribution Channels      Hospital PharmacyRetail PharmacyOnline PharmacyBy GeographyNorth America (U.S. and Canada)Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)Latin America (Brazil, Mexico, and Rest of Latin America)Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)
Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/eye-supplements-market-100347
Have a Look at Related Reports:Neonatal Intensive Care Market Size, Share & Industry Analysis, By Product (Neonatal Incubators, Neonatal Phototherapy Equipment, Neonatal Ventilators, Neonatal Monitors, and Others), By End User (Hospitals, and Specialty Clinics), and Regional Forecast, 2020-2027Lymphoma Treatment Market Size, Share & Industry Analysis, By Therapy (Immunotherapy, Targeted Therapy, Chemotherapy, and Others), By Disease Type (Non-Hodgkin Lymphoma, and Hodgkin Lymphoma), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and Regional Forecast, 2019-2026Diabetic Neuropathy Market Size, Share & Industry Analysis, By Disease Type (Peripheral, Autonomic, Proximal, and Focal), By Drug Class (Anti-Depressants, Anti-Seizures, Opioid, Non-Steroidal Anti-Inflammatory, and others), By Distribution Channel (Hospital Pharmacies, Retails Pharmacies & Stores, and Online Pharmacies), and Regional Forecast, 2019-2026Teleradiology Market Size, Share & Industry Analysis, By Imaging Technique (X-Ray, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Ultrasound, Nuclear Medicine, and Others), By Component (Services & Software, and Product), By End User (Hospitals & Clinics, Diagnostic Centers and Others), and Regional Forecast, 2019-2026Transcatheter Heart Valve Replacement (THVR) Market Size, Share & Industry Analysis, By Product Type (Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral Valve Replacement (TMVR), and Transcatheter Pulmonary Valve Replacement (TPVR)), By End User (Hospitals, and Specialty Clinics& Others), and Regional Forecast, 2019-2026
About Us:Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.